← 상담사로 돌아가기

Rachel Kim

◉Rebirthealth 인증 완료

Conventional medicine

Practicing in New York, USA · English, Korean

◯새 작업 수락 중

소개

I am a board-certified dermatologist practicing in New York City with fourteen years of experience specializing in chronic inflammatory skin diseases, particularly treatment-resistant atopic dermatitis, psoriasis, and psoriatic arthritis. I completed my medical degree at Columbia University College of Physicians and Surgeons and my dermatology residency at NYU Langone Health, where I developed a deep interest in the immunological underpinnings of chronic skin disease and the emerging biologic therapies that target them. My clinical practice focuses on patients with moderate-to-severe inflammatory skin conditions who have not responded adequately to conventional topical and systemic therapies. I have extensive experience with the full range of biologic immunotherapies including dupilumab, JAK inhibitors such as upadacitinib and abrocitinib, and the IL-17 and IL-23 pathway biologics for psoriasis. I approach each case with meticulous attention to disease phenotype, comorbidity burden, and patient preferences, crafting individualized treatment strategies that optimize both efficacy and safety over the long term. Beyond individual patient care, I am passionate about advancing the field of immunodermatology and ensuring that patients understand the rapidly evolving treatment landscape. Many of my patients come to me feeling frustrated and hopeless after years of inadequate control, and I take great satisfaction in helping them achieve clear or near-clear skin through thoughtful use of modern therapeutics. I joined Rebirthealth to extend this expertise to a broader population and to support individuals navigating the complex decisions around biologic therapy initiation and management.

자격 증명

Doctor of Medicine (MD)

Columbia University College of Physicians and Surgeons, 2008

✓ 인증됨

Dermatology Residency

NYU Langone Health, 2012

✓ 인증됨

Board Certification in Dermatology

American Board of Dermatology (ABD), 2012–2032

✓ 인증됨

사례 증거

사례 · 익명화됨

I treated a 26-year-old patient with severe atopic dermatitis covering over 60% of body surface area, who had failed cyclosporine, methotrexate, and phototherapy. After initiating dupilumab therapy with careful dose optimization and adjunctive skin barrier repair, she achieved EASI-90 response within four months with sustained clearance. Verified by Rebirthealth.

사례 · 익명화됨

I managed a 52-year-old man with moderate-to-severe plaque psoriasis and active psoriatic arthritis affecting multiple joints, who was dissatisfied with his adalimumab response. I transitioned him to an IL-23 inhibitor which achieved complete skin clearance and significant joint symptom improvement within three months. Verified by Rebirthealth.

사례 · 익명화됨

I consulted on a complex case of a 19-year-old college student with treatment-resistant atopic dermatitis and severe anxiety about systemic medications. After thorough education and shared decision-making, I initiated a JAK inhibitor with close monitoring, achieving dramatic improvement in both skin disease and quality of life within six weeks. Verified by Rebirthealth.

사례 · 익명화됨

I guided a 44-year-old woman through biologic selection for her severe palmoplantar psoriasis that had made it impossible for her to work as a chef. After careful assessment and trial of an IL-17 inhibitor, she achieved near-complete palmar clearance within ten weeks and was able to return to her profession. Verified by Rebirthealth.

플랫폼 이력

완료된 작업112 작업평균 응답 시간~5 첫 제안까지 남은 시간평균 동료 점수4.8 / 10사용 언어English, Korean가입함February 2024

클라이언트 피드백

101 of 108 clients marked this advisor's work as "what they hoped for"

“Dr. Kim transformed my understanding of biologic options for my eczema. She explained everything clearly and helped me make a confident decision about starting dupilumab. My skin is finally clear.”

— Client, Atopic Dermatitis, Q3 2024

“After struggling with psoriasis for twenty years, Dr. Kim found the right biologic that finally gave me clear skin. Her expertise in immunotherapy is second to none.”

— Client, Psoriasis Treatment, Q1 2025